cyclopharm.com.au | Cyclopharm | innovative solutions in nuclear

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔

Meta Tags

Title	Cyclopharm \| innovative solutions in nuclear
Description	Visit the homepage of the Cyclopharm Global corporate website. Cyclopharm provide innovative solutions in nuclear medicine by manufacturing and selling Technegas
Keywords	N/A

Server Information

WebSite	cyclopharm.com.au
Host IP	35.243.179.0
Location	United States

Related Websites

                        Site
                        Rank
                    

More to Explore

cyclopharm.com.au Valuation

US$1,124

Last updated: 2023-05-13 22:11:07

cyclopharm.com.au has Semrush global rank of 0. cyclopharm.com.au has an estimated worth of US$ 1,124, based on its estimated Ads revenue. cyclopharm.com.au receives approximately 129 unique visitors each day. Its web server is located in United States, with IP address 35.243.179.0. According to SiteAdvisor, cyclopharm.com.au is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$1,124
Daily Ads Revenue	US$1
Monthly Ads Revenue	US$31
Yearly Ads Revenue	US$373
Daily Unique Visitors	8
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
cyclopharm.com.au.	A	299	IP: 35.243.179.0
cyclopharm.com.au.	NS	86400	NS Record: theo.ns.cloudflare.com.
cyclopharm.com.au.	NS	86400	NS Record: ashley.ns.cloudflare.com.
cyclopharm.com.au.	MX	300	MX Record: 0 cyclopharm-com-au.mail.protection.outlook.com.
cyclopharm.com.au.	TXT	300	TXT Record: MS=ms14707330
cyclopharm.com.au.	TXT	300	TXT Record: v=spf1 +mx include:spf.protection.outlook.com include:spf.unibithosting.com.au -all

HtmlToTextCheckTime:2023-05-13 22:11:07

You are in Cyclopharm Change Location Select a Location Global Europe – English Europe – German Europe – French Australia Asia Canada --> Cyclopharm About Us Investor Centre Our Products Partnerships Contact Us --> Innovative solutions in nuclear medicine Discover More Whats new Cyclopharm (ASX:CYC) | Bell Potter Healthcare Conference 2022 Presentation Whats new We are excited to announce our partnership with Jubilant Radiopharma for the distribution of RUBY-FILL® throughout Europe Whats new Cyclopharm partners with McMaster University to Evaluate Technegas® use and risks of COVID-19 Whats new Lung Imaging and COVID-19 Impact Read recommendations about Technegas® Whats new Technegas® NDA pending US FDA review The Technegas® NDA was accepted by FDA on 26 March 2020. Learn more. R&D With over 30 years of experience in the field of nuclear and respiratory medicine, Cyclopharm continues to enhance and develop medical innovations. Discover More About Us Cyclopharm

HTTP Headers

HTTP/1.1 301 Moved Permanently
Server: nginx
Date: Wed, 22 Dec 2021 05:37:31 GMT
Content-Type: text/html
Content-Length: 162
Connection: keep-alive
Keep-Alive: timeout=20
Location: https://cyclopharm.com.au/

HTTP/2 302 
server: nginx
date: Wed, 22 Dec 2021 05:37:31 GMT
content-type: text/html; charset=UTF-8
content-length: 0
location: https://www.cyclopharm.com/
x-powered-by: WP Engine
x-cacheable: non200
cache-control: max-age=600, must-revalidate
x-cache: HIT: 1
x-cache-group: normal

HTTP/2 200 
server: nginx
date: Wed, 22 Dec 2021 05:37:31 GMT
content-type: text/html; charset=UTF-8
content-length: 34661
vary: Accept-Encoding
vary: Accept-Encoding
set-cookie: gdpr[consent_types]=%5B%5D; expires=Thu, 22-Dec-2022 05:06:36 GMT; Max-Age=31536000; path=/
set-cookie: gdpr[allowed_cookies]=%5B%22Google%20Analytics%22%2C%22IRM%20Investor%20Centre%22%5D; expires=Thu, 22-Dec-2022 05:06:36 GMT; Max-Age=31536000; path=/
link: ; rel="https://api.w.org/"
link: ; rel="alternate"; type="application/json"
link: ; rel=shortlink
x-powered-by: WP Engine
x-cacheable: SHORT
vary: Accept-Encoding,Cookie
cache-control: max-age=600, must-revalidate
x-cache: HIT: 2
x-cache-group: normal
accept-ranges: bytes

cyclopharm.com.au valuation and analysis